CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shanghai Shyndec Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shanghai Shyndec Pharmaceutical Co Ltd
No. 378 Jianlu Road, Pudong New Area
Phone: +86 2152372865p:+86 2152372865 SHANGHAI, SHA  200137  China Ticker: 600420600420
Business Summary
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products are antibiotics, circulatory system drugs and biological products, including garlic oil soft capsules, lecithin soft capsules and deep-sea fish oil soft capsules. Its bulk pharmaceutical chemicals (BPCs) include macrolide antibiotics, antiviral, anti-tumor, cardiovascular, hormones and weight loss drugs. The Company also offers topical preparations, such as gynecological suppositories and dermatology preparations.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2099 Food preparations, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JihuiXu 58 9/12/2024 9/12/2024
President, Vice Chairman of the Board YongLiu 55 9/12/2024 4/1/2021
Chief Financial Officer JingZu 54 3/28/2024
9 additional Officers and Directors records available in full report.

Business Names
Business Name
600420
Shanghai Modern Pharmaceutical Co., Ltd.
Sinopharm Chuan Kang Pharmaceutical Co.,Ltd.
Wuhan Zhonglian Pharmaceutical Group Co., Ltd.

General Information
Number of Employees: 11,608 (As of 12/31/2023)
Outstanding Shares: 1,341,172,692 (As of 9/30/2024)
Shareholders: 34,306
Stock Exchange: SHA
Fax Number: +86 2158480136


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024